Immunotherapeutic effects of chitin in comparison with chitosan against Leishmania major infection

Parasitol Int. 2016 Apr;65(2):99-104. doi: 10.1016/j.parint.2015.10.007. Epub 2015 Oct 28.

Abstract

Chitin and chitosan microparticles (MPs) are important immune system stimulators. The aim of this study was to evaluate the protective effects of these compounds in comparison with each other against Leishmania infection in BALB/c mice infected with Leishmania major (L. major). Female BALB/c mice were injected subcutaneously with 2×10(5) promastigotes. Chitin and/or chitosan MPs (<40 μm) were subcutaneously injected in the BALB/c mice with two-day intervals until two weeks. Mice in all groups were sacrificed at 12 weeks post-infection. Enumeration of viable parasites was performed using limiting dilution assay. Furthermore, the animals (5 mice/group) were sacrificed two weeks post-infection. The lymph node cells were isolated and the effects of the chitinous MPs on the proliferation and production of cytokines such as tumor necrosis factor alpha (TNF-α) and interleukin-10 (IL-10) were determined. The mean sizes of lesions were significantly smaller in chitin (0.6±0.12 mm) and chitosan treated groups (1.2±0.8 mm) than in the control group (6.2±1.7 mm) (P<0.05). The parasite load in the lymph nodes of the treated mice was significantly lower than that in the lymph nodes of controls (1.31×10(6) vs 8.24×10(7) parasite/lymph node [P=0.032] and 7.49×10(6) vs 8.24×10(7) parasite/lymph node [P=0.05] for chitin and chitosan MPs treatment, respectively). We found that chitinous MPs induced cell proliferation and that chitin but not chitosan increased TNF-α and IL-10 production. Chitin appears that it has more effect than chitosan against leishmaniasis. The current study revealed that chitinous MPs had significant activity against L. major and could be considered as new therapeutic modality in leishmaniasis.

Keywords: Chitin; Chitosan; Immunotherapeutic effect; Leishmania major.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic*
  • Animals
  • Cell Proliferation
  • Chitin / administration & dosage
  • Chitin / immunology*
  • Chitosan / administration & dosage
  • Chitosan / immunology*
  • Cytokines / biosynthesis
  • Cytokines / immunology
  • Female
  • Immunotherapy
  • Interferon-gamma / biosynthesis
  • Leishmania major* / immunology
  • Leishmania major* / physiology
  • Leishmaniasis, Cutaneous / immunology*
  • Leishmaniasis, Cutaneous / parasitology
  • Leishmaniasis, Cutaneous / prevention & control
  • Leishmaniasis, Cutaneous / therapy*
  • Lymph Nodes / cytology
  • Lymph Nodes / immunology
  • Mice, Inbred BALB C
  • Parasite Load
  • Subcutaneous Absorption
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • Adjuvants, Immunologic
  • Cytokines
  • Tumor Necrosis Factor-alpha
  • Chitin
  • Interferon-gamma
  • Chitosan